Citadel Advisors’s Delcath Systems DCTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$600K Sell
64,700
-48,400
-43% -$469K ﹤0.01% 8849
2025
Q4
$1.14M Buy
113,100
+33,800
+43% +$336K ﹤0.01% 7095
2025
Q3
$852K Buy
79,300
+53,200
+204% +$594K ﹤0.01% 7888
2025
Q2
$355K Sell
26,100
-12,800
-33% -$178K ﹤0.01% 9411
2025
Q1
$495K Sell
38,900
-18,500
-32% -$263K ﹤0.01% 8500
2024
Q4
$691K Buy
57,400
+34,300
+148% +$362K ﹤0.01% 7862
2024
Q3
$209K Sell
23,100
-11,800
-34% -$102K ﹤0.01% 10057
2024
Q2
$292K Buy
34,900
+200
+0.6% +$1.27K ﹤0.01% 9194
2024
Q1
$166K Sell
34,700
-3,100
-8% -$13.4K ﹤0.01% 10616
2023
Q4
$157K Buy
37,800
+18,300
+94% +$59.9K ﹤0.01% 10311
2023
Q3
$79K Buy
+19,500
New +$91.4K ﹤0.01% 11198

Other funds holding DCTH

Citadel Advisors's DCTH Position: Q1 2026 in Review

Citadel Advisors reduced its Delcath Systems (DCTH) stake by 79% in Q1 2026, selling an estimated $2.82M and leaving 77,264 shares worth $717K. The position accounts for ﹤0.01% of the portfolio, ranked #8449.

Citadel Advisors first reported a position in DCTH in Q4 2022 and has held it in 13 quarters since. The position peaked at $10.9M in Q2 2025. 121 funds tracked by Wall St. Rank hold DCTH as of Q1 2026.

  • Citadel Advisors held 77,264 shares of Delcath Systems worth $717K as of Q1 2026.
  • Citadel Advisors sold 291,601 Delcath Systems shares in Q1 2026, an estimated $2.82M.
  • Delcath Systems made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8449 holding.
  • Citadel Advisors first reported a position in Delcath Systems in Q4 2022 and has held it in 13 quarters since.
  • Citadel Advisors's Delcath Systems position peaked at $10.9M in Q2 2025.
  • 121 funds tracked by Wall St. Rank held Delcath Systems as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.